bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) traded down 25.7% during trading on Friday . The company traded as low as $0.30 and last traded at $0.30. 5,501 shares changed hands during mid-day trading, an increase of 18% from the average session volume of 4,647 shares. The stock had previously closed at $0.40.
bioAffinity Technologies Stock Performance
The stock’s fifty day moving average is $0.74 and its 200-day moving average is $0.85.
About bioAffinity Technologies
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.
See Also
- Five stocks we like better than bioAffinity Technologies
- What is Insider Trading? What You Can Learn from Insider Trading
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- How to Use the MarketBeat Stock Screener
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- How to Evaluate a Stock Before BuyingÂ
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
